OtherBasic Science Investigations
Hypoxia-Specific Tumor Imaging with 18F-Fluoroazomycin Arabinoside
Morand Piert, Hans-Jürgen Machulla, Maria Picchio, Gerald Reischl, Sybille Ziegler, Piyush Kumar, Hans-Jürgen Wester, Roswitha Beck, Alexander J.B. McEwan, Leonard I. Wiebe and Markus Schwaiger
Journal of Nuclear Medicine January 2005, 46 (1) 106-113;
Morand Piert
Hans-Jürgen Machulla
Maria Picchio
Gerald Reischl
Sybille Ziegler
Piyush Kumar
Hans-Jürgen Wester
Roswitha Beck
Alexander J.B. McEwan
Leonard I. Wiebe
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Hypoxia-Specific Tumor Imaging with 18F-Fluoroazomycin Arabinoside
Morand Piert, Hans-Jürgen Machulla, Maria Picchio, Gerald Reischl, Sybille Ziegler, Piyush Kumar, Hans-Jürgen Wester, Roswitha Beck, Alexander J.B. McEwan, Leonard I. Wiebe, Markus Schwaiger
Journal of Nuclear Medicine Jan 2005, 46 (1) 106-113;
Hypoxia-Specific Tumor Imaging with 18F-Fluoroazomycin Arabinoside
Morand Piert, Hans-Jürgen Machulla, Maria Picchio, Gerald Reischl, Sybille Ziegler, Piyush Kumar, Hans-Jürgen Wester, Roswitha Beck, Alexander J.B. McEwan, Leonard I. Wiebe, Markus Schwaiger
Journal of Nuclear Medicine Jan 2005, 46 (1) 106-113;
Related Articles
Cited By...
- Concomitant [18F]F-FAZA and [18F]F-FDG Imaging of Gynecological Cancer Xenografts: Insight into Tumor Hypoxia
- GdDO3NI allows imaging of hypoxia after brain injury
- First Evaluation of PET-Based Human Biodistribution and Dosimetry of 18F-FAZA, a Tracer for Imaging Tumor Hypoxia
- In Vivo Hypoxia PET Imaging Quantifies the Severity of Arthritic Joint Inflammation in Line with Overexpression of Hypoxia-Inducible Factor and Enhanced Reactive Oxygen Species Generation
- 18F-FAZA PET Imaging Response Tracks the Reoxygenation of Tumors in Mice upon Treatment with the Mitochondrial Complex I Inhibitor BAY 87-2243
- Comparison of 18F-Fluoroazomycin-Arabinofuranoside and 64Cu-Diacetyl-Bis(N4-Methylthiosemicarbazone) in Preclinical Models of Cancer
- Prognostic and Predictive Significance of Plasma HGF and IL-8 in a Phase III Trial of Chemoradiation with or without Tirapazamine in Locoregionally Advanced Head and Neck Cancer
- Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging
- Location, Location, Location-Makes All the Difference for Hypoxia in Lung Tumors
- Hypoxia in Models of Lung Cancer: Implications for Targeted Therapeutics
- Quantitative Assessment of Hypoxia Kinetic Models by a Cross-Study of Dynamic 18F-FAZA and 15O-H2O in Patients with Head and Neck Tumors
- Pharmacologically Increased Tumor Hypoxia Can Be Measured by 18F-Fluoroazomycin Arabinoside Positron Emission Tomography and Enhances Tumor Response to Hypoxic Cytotoxin PR-104
- Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET
- Reply: Intratumoral Spatial Distribution of Hypoxia and Angiogenesis Assessed by 18F-FAZA and 125I-Gluco-RGD Autoradiography
- Molecular Imaging of Hypoxia
- Molecular Imaging of Metastatic Potential
- Applications of Nitroimidazole In Vivo Hypoxia Imaging in Ischemic Stroke
- Correlative Imaging of Hypoxia and Angiogenesis in Oncology
- Intratumoral Spatial Distribution of Hypoxia and Angiogenesis Assessed by 18F-FAZA and 125I-Gluco-RGD Autoradiography
- Nuclear Imaging Probes: from Bench to Bedside
- Pretreatment 18F-FAZA PET Predicts Success of Hypoxia-Directed Radiochemotherapy Using Tirapazamine
- Experience of PET for target localisation in radiation oncology
- Modulation of intratumoral hypoxia by the epidermal growth factor receptor inhibitor gefitinib detected using small animal PET imaging